no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity
|
Smallshaw, Joan E. |
|
2010 |
28 |
12 |
p. 2428-2435 8 p. |
article |
2 |
An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination
|
Schmeisser, Falko |
|
2010 |
28 |
12 |
p. 2442-2449 8 p. |
article |
3 |
An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response
|
Hu, Xi-Dan |
|
2010 |
28 |
12 |
p. 2408-2415 8 p. |
article |
4 |
A novel canine favored CpG oligodeoxynucleotide capable of enhancing the efficacy of an inactivated aluminum-adjuvanted rabies vaccine of dog use
|
Ren, Jiling |
|
2010 |
28 |
12 |
p. 2458-2464 7 p. |
article |
5 |
Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine
|
Laufer, Alison S. |
|
2010 |
28 |
12 |
p. 2450-2457 8 p. |
article |
6 |
Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens
|
Brahmakshatriya, Vinayak R. |
|
2010 |
28 |
12 |
p. 2388-2396 9 p. |
article |
7 |
Editorial Board
|
|
|
2010 |
28 |
12 |
p. CO2- 1 p. |
article |
8 |
Fear, misinformation, and innumerates: How the Wakefield paper, the press, and advocacy groups damaged the public health
|
Poland, Gregory A. |
|
2010 |
28 |
12 |
p. 2361-2362 2 p. |
article |
9 |
Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar®)
|
Rozenbaum, Mark H. |
|
2010 |
28 |
12 |
p. 2367-2369 3 p. |
article |
10 |
Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine
|
Firbas, Christa |
|
2010 |
28 |
12 |
p. 2397-2407 11 p. |
article |
11 |
Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: Using PRNT50 as an endpoint for immunogenicity
|
Reisler, Ronald B. |
|
2010 |
28 |
12 |
p. 2436-2441 6 p. |
article |
12 |
Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection
|
Seib, Kate L. |
|
2010 |
28 |
12 |
p. 2416-2427 12 p. |
article |
13 |
Neutralizing antibody response after intradermal rabies vaccination in hemodialysis patients
|
Tanisaro, Theeraphab |
|
2010 |
28 |
12 |
p. 2385-2387 3 p. |
article |
14 |
Staphylococcus aureus vaccine for orthopedic patients: An economic model and analysis
|
Lee, Bruce Y. |
|
2010 |
28 |
12 |
p. 2465-2471 7 p. |
article |
15 |
Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation
|
Baguelin, Marc |
|
2010 |
28 |
12 |
p. 2370-2384 15 p. |
article |
16 |
Vaccine adjuvants: A priority for vaccine research
|
Harandi, Ali M. |
|
2010 |
28 |
12 |
p. 2363-2366 4 p. |
article |